Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers.

Abstract

Experiments on estrogen metabolism, formation of DNA adducts, mutagenicity, cell transformation and carcinogenicity have led to and supported the hypothesis that the reaction of specific estrogen metabolites, mostly the electrophilic catechol estrogen-3,4-quinones, with DNA can generate the critical mutations to initiate breast and other human cancers. Analysis of depurinating estrogen-DNA adducts in urine demonstrates that women at high risk of, or with breast cancer, have high levels of the adducts, indicating a critical role for adduct formation in breast cancer initiation. Men with prostate cancer or non-Hodgkin lymphoma also have high levels of estrogen-DNA adducts. This knowledge of the first step in cancer initiation suggests the use of specific antioxidants that can block formation of the adducts by chemical and biochemical mechanisms. Two antioxidants, N-acetylcysteine and resveratrol, are prime candidates to prevent breast and other human cancers because in various M in vitro and in vivo experiments, they reduce the formation of estrogen-DNA adducts.

• Authors: Ercole L Cavalieri, Eleanor G Rogan
• Journal: Future oncology (London, England) (Future Oncol) Vol. 6 Issue 1 Pg. 75-91 (Jan 2010) ISSN: 1744-8301 [Electronic] England
• PMID: 20021210 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Antineoplastic Agents
• Antioxidants
• DNA Adducts
• Estrogens
• Stilbenes
• Resveratrol
• Acetylcysteine

Topics

• Acetylcysteine (pharmacology)
• Animals
• Antineoplastic Agents (pharmacology)
• Antioxidants (pharmacology)
• Breast Neoplasms (etiology, prevention & control)
• DNA Adducts (adverse effects, metabolism)
• Estrogens (metabolism)
• Female
• Humans
• Male
• Neoplasms (etiology, prevention & control)
• Resveratrol
• Stilbenes (pharmacology)